This protective effect is mainly advantageous for type 2 diabetes, where beta cells are still present but not functioning well
There are currently no clinical trials investigating the use of GLP-1RAs in patients with PTSD or OCD, leaving the clinical validation of these findings unexplored
Ramratnam M, Sharma RK, DAuria S, Lee SJ, Wang D, Huang XY, Ahmad F (2014) Transgenic knockdown of cardiac sodium/glucose cotransporter 1 (SGLT1) attenuates PRKAG2 cardiomyopathy, whereas transgenic overexpression of cardiac SGLT1 causes pathologic hypertrophy and dysfunction in mice
and Metabolism 88 (10), 46964701
Receive personalised guidance to help you through your results.
Some experience mild nausea or headaches early on, but these usually fade quickly